# Investigation of Antidepressant Efficacy of Oral Ketamine Treatment

> **NCT02992496** · PHASE2 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 60 (estimated)

## Conditions studied

- Major Depressive Episode

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam Hydrochloride

## Key facts

- **NCT ID:** NCT02992496
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-24
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992496, "Investigation of Antidepressant Efficacy of Oral Ketamine Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02992496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*